CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...